Characteristics | control group (n = 26) | titration group (n = 25) | SMD [95%CI] |
---|---|---|---|
Age; yr | 48 (8) | 47 (9) | 0.11 [-0.45,0.67] |
Sex; male/female | 14/12 | 12/13 | 0.12 [-0.43,0.67] |
BMI; kg·m− 2 | 25.1 (2.9) | 24.6 (3.5) | 0.13 [-0.43,0.70] |
ASA, II, n (%) | 0(0) | 0(0) | Â |
III, n (%) | 26 (100) | 25 (100) | Â |
Hemoglobin, g·dl− 1 | 13.3(1.6) | 13.2 (1.4) | 0.12 [-0.44,0.68] |
Smoking, n (%) | 8 (31) | 9 (36) | 0.11 [-0.44,0.66] |
Comorbidities, n (%) | Â | Â | 0.51 [-0.05,1.06] |
Hypertension | 7 (27) | 5 (20) | Â |
Diabetes | 3 (12) | 2 (8) | Â |
Heart disease | 2 (8) | 0 (0) | Â |
Position, n (%) | Â | Â | 0.13 [-0.42,0.68] |
Supine | 23 (88) | 21 (84) | Â |
Lateral | 3 (12) | 4 (16) | Â |
Type of tumor, n (%) | Â | Â | 0.46 [-0.10,1.02] |
Glioma | 13 (50) | 12 (48) | Â |
Meningioma | 7 (27) | 10 (40) | Â |
Craniopharyngioma | 1 (4) | 1 (4) | Â |
Pituitary tumor | 1 (4) | 0 (0) | Â |
Metastatic tumor | 1 (4) | 1 (4) | Â |
Others | 3 (11) | 1 (4) | Â |